| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROGASTROENTEROLOGY |
1 Physiology Unit, St Mark’s Hospital, Harrow, Middlesex, UK
2 Department of Radiology, St Mark’s Hospital, Harrow, Middlesex, UK
3 Department of Metabolic Medicine, Imperial College, Hammersmith Campus, London, UK
4 Department of Endocrinology, Hemel Hempstead Hospital, Hertfordshire, UK
Correspondence to:
Correspondence to:
Dr A V Emmanuel
Physiology Unit, St Mark’s Hospital, Harrow HA1 3UJ, UK; a.emmanuel{at}imperial.ac.uk
ABSTRACT
Background: Diabetic gastroparesis is a disabling condition with no consistently effective treatment. In animals, ghrelin increases gastric emptying and reverses postoperative ileus. We present the results of a double blind, placebo controlled, crossover study of ghrelin in gastric emptying in patients with diabetic gastroparesis.
Methods: Ten insulin requiring diabetic patients (five men, six type I) referred with symptoms indicative of gastroparesis received a two hour infusion of either ghrelin (5 pmol/kg/min) or saline on two occasions. Blood glucose was controlled by euglycaemic clamp. Gastric emptying rate (GER) was calculated by real time ultrasound following a test meal. Blood was sampled for ghrelin, growth hormone (GH), and pancreatic polypeptide (PP) levels. Cardiovagal neuropathy was assessed using the Mayo Clinic composite autonomic severity score (range 0 (normal)–3).
Results: Baseline ghrelin levels were mean 445 (SEM 36) pmol/l. Ghrelin infusion achieved a peak plasma level of 2786 (188) pmol/l at 90 minutes, corresponding to a peak GH of 70.9 (19.8) pmol/l. Ghrelin increased gastric emptying in seven of 10 patients (30 (6)% to 43 (5)%; p = 0.04). Impaired cardiovagal tone correlated inversely with peak postprandial PP values (p<0.05) but did not correlate with GER.
Conclusions: Ghrelin increases gastric emptying in patients with diabetic gastroparesis. This is independent of vagal tone. We propose that analogues of ghrelin may represent a new class of prokinetic agents.
Abbreviations: GH, growth hormone; GHS-R, growth hormone secretagogue receptor; PP, pancreatic polypeptide; CAN, cardiovagal autonomic neuropathy; GER, gastric emptying rate; BMI, body mass index; CASS, composite autonomic severity score
Keywords: ghrelin; diabetic gastroparesis; pancreatic polypeptide
Related Article
Gut 2005 54: 1667.
This article has been cited by other articles:
|
|
 |
|
  K. C. Lasseter, L. Shaughnessy, D. Cummings, J. C. Pezzullo, W. Wargin, R. Gagnon, J. Oliva, and G. Kosutic Ghrelin Agonist (TZP-101): Safety, Pharmacokinetics and Pharmacodynamic Evaluation in Healthy Volunteers: A Phase I, First-in-Human Study J. Clin. Pharmacol., February 1, 2008; 48(2): 193 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Ahima Antagonism of Ghrelin for Glycemic Control in Type 2 Diabetes Mellitus? Endocrinology, November 1, 2007; 148(11): 5173 - 5174. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Abrahamsson Treatment options for patients with severe gastroparesis Gut, June 1, 2007; 56(6): 877 - 883. [Full Text] [PDF]
|
|
|
|
 |
|
 E. T. Vestergaard, T. K. Hansen, L. C. Gormsen, P. Jakobsen, N. Moller, J. S. Christiansen, and J. O. L. Jorgensen Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1829 - E1836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Piccoli, L. Degen, C. MacLean, S. Peter, L. Baselgia, F. Larsen, C. Beglinger, and J. Drewe Pharmacokinetics and Pharmacodynamic Effects of an Oral Ghrelin Agonist in Healthy Subjects J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1814 - 1820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Sallam, H. M. Oliveira, H. T. Gan, D. N. Herndon, and J. D. Z. Chen Ghrelin improves burn-induced delayed gastrointestinal transit in rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R253 - R257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Murphy, W. S. Dhillo, and S. R. Bloom Gut Peptides in the Regulation of Food Intake and Energy Homeostasis Endocr. Rev., December 1, 2006; 27(7): 719 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Naslund and J. G. Kral Impact of Gastric Bypass Surgery on Gut Hormones and Glucose Homeostasis in Type 2 Diabetes Diabetes, December 1, 2006; 55(Supplement_2): S92 - S97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Shimizu, E. C. Chang, A. D. Shafton, D. M. Ferens, G. J. Sanger, J. Witherington, and J. B. Furness Evidence that stimulation of ghrelin receptors in the spinal cord initiates propulsive activity in the colon of the rat J. Physiol., October 1, 2006; 576(1): 329 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. O. L. Jorgensen A simple twist of science: the convoluted tale of ghrelin continues. J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3279 - 3280. [Full Text] [PDF]
|
|
|
|
|
|
F. Levin, T. Edholm, P. T. Schmidt, P. Gryback, H. Jacobsson, M. Degerblad, C. Hoybye, J. J. Holst, J. F. Rehfeld, P. M. Hellstrom, et al. Ghrelin Stimulates Gastric Emptying and Hunger in Normal-Weight Humans J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3296 - 3302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Tack, I Depoortere, R Bisschops, C Delporte, B Coulie, A Meulemans, J Janssens, and T Peeters Influence of ghrelin on interdigestive gastrointestinal motility in humans Gut, March 1, 2006; 55(3): 327 - 333. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
